Staff Data Search - جامعة الزقازيق

Personal Website
Curriculum Vitae

Amira Mohamed Mohamed Ali Elganayny

Faculty pharmacy - Department Microbiology and Immunology Department
NULL

Scientific degrees

BSc In NULL, [1997]
MSc In NULL, [2005]

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 14/9/1998
Doctor Assisant : 13/3/2005
Doctor : 25/10/2011
Professor Assisant : 27/3/2018
Professor : 29/4/2023

Publications

1 - Studies on Virulence Factors of Candida Albicans

2 - Aspergillus nidulans hypB encodes a Sec7-domain protein important for hyphal morphogenesis (2008).

3 - Aspergillus nidulans UDP-galactopyranose mutase, encoded by ugmA plays key roles in colony growth, hyphal morphogensis, and conidiation (2008).

4 - Aspergillus nidulans UDP-glucose-4-epimerase UgeA has multiple roles in wall architecture, hyphal morphogenesis, and asexual development (2010).

5 - Quantifying the importance of galactofuranose in Aspergillus nidulans hyphal wall surface organization by atomic force microscopy (2011).

6 - Roles of the Aspergillus nidulans UDP-galactofuranose transporter, UgtA in hyphal morphogenesis, cell wall architecture, conidiation, and drug sensitivity. (2011).

7 - Aspergillus nidulans galactofuranose biosynthesis affects antifungal drug sensitivity (2012).

8 - The Study of biofilm formation by Extended Spectrum Beta lactamase producing Klebsiella isolates (2014).

9 - Generation of Aspergillus nidulans mutants with deleted GDP-mannose transporters by fusion PCR (2015).

10 - Phenotypic and Genotypic Detection of Beta-Lactams Resistance in Klebsiella pneumonia from Egyptian Hospitals Revealed Carbapenem Resistance by OXA and NDM Genes (2016).

11 - Integron occurrence is linked to reduced biocide susceptibility in multidrug resistant Pseudomonas aeruginosa (2017).

12 - Prevention of Bacterial Biofilm Formation on Soft Contact Lenses Using Natural Compounds (2017).

13 - Deletion of Aspergillus nidulans GDP-mannose transporters affects hyphal morphometry, cell wall architecture, spore surface character, cell adhesion, and biofilm formation. (2017).

14 - Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans (2018).

15 - Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans (2018).

16 - Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections (2020).

17 - Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic Escherichia coli isolates in relation to the antimicrobial resistance (2020).

18 - Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus (2020).

19 - Back to Nature: Combating Candida albicans Biofilm, Phospholipase and Hemolysin Using Plant Essential Oils (2021).

20 - The Link between Occurrence of Class I Integron and Acquired Aminoglycoside Resistance in Clinical MRSA Isolates (2021).

21 - Could the analgesic drugs, paracetamol and indomethacin, function as quorum sensing inhibitors (2021).

22 - Impeding efflux-mediated resistance in Staphylococcus aureus (2022).

23 - Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus (2022).

24 - In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates (2022).

25 - Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates (2022).

26 - In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates (2022).

27 - Repurposing of some non-antimicrobial FDA approved drugs to combat antimicrobial resistance and virulence of some pathogenic microbes (2024).

28 - Study on strategies to combat antibiotic resistance in clinical isolates of Staphylococcus aureus (2024).

29 - Inhibition of virulence factors of methicillin-resistant Staphylococcus aureus (2024).

30 - Inhibition of virulence factors of Proteus mirabilis isolated from urinary tract infection, diabetic foot infections and burn wound infections (2024).

31 - STUDIES ON VIRULENCE FACTORS OF CANDIDA ALBICANS (2024).

32 - The galactofuranose biosynthesis pathway is a promising antifungal drug target in the cell wall of Aspergillus nidulans (2024).

33 - Bioremediation of environmental plastic polymer pollutants by microbial enzymes (2024).

34 - Evaluation of polymethyl-methacrylate and acetal denture base resins processed by two different techniques before and after nano-chlorohexidine surface treatment (2023).

35 - Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota (2023).

36 - Optimizing Eco-Friendly Degradation of Polyvinyl Chloride (PVC) Plastic Using Environmental Strains of Malassezia Species and Aspergillus fumigatus (2023).

37 - Impact of short chain fatty acids (SCFAs) on antimicrobial activity of new β-lactam/β-lactamase inhibitor combinations and on virulence of Escherichia coli isolates (2023).

38 - Genome Analysis of Pseudomonas aeruginosa Strains from Chronically Infected Patients with High Levels of Persister Formation (2023).

39 - Isolation and Characterization of Bacteriophages Infecting Pseudomonas aeruginosa (2024).

40 - Isolation of a bacteriophage targeting Pseudomonas aeruginosa and exhibits a promising in vivo efficacy (2023).

41 - Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae (2024).

42 - Eradication of bacterial-biofilm isolated from patients with dental plaque and dental caries (2024).

43 - Study on resistance of clinical Klebsiella pneumoniae to carbapenem (2024).

44 - Evaluation of Quorum Sensing Inhibitors on Pathogenic Bacteria Isolated from Ventilator Associated Pneumonia Patients (2024).

45 - A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa (2023).

Research Area